Date: 01/15/2020
Product: Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-060-3
Company: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Recall Reason: Lack of Assurance of Sterility
Classification: Class II
Report Date: 20200311